02639nas a2200265 4500000000100000008004100001653003900042653001100081653001400092653001100106653001400117653001100131653001600142100001400158700001700172700001400189700001300203700001100216245009900227856012200326300001000448490000600458520189500464022001402359 2013 d10aNeglected tropical diseases (NTDs)10aGender10aTreatment10aAccess10aAdherence10aUganda10aCommunities1 aRilkoff H1 aTukahebwa EM1 aFleming F1 aLeslie J1 aCole D00aExploring gender dimensions of treatment programmes for neglected tropical diseases in Uganda. uhttp://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0002312&representation=PDF ae23120 v73 a
BACKGROUND: Gender remains a recognized but relatively unexamined aspect of the potential challenges for treatment programmes for Neglected Tropical Diseases (NTDs). We sought to explore the role of gender in access to treatment in the Uganda National Neglected Tropical Disease Control Programme.
METHODOLOGY/PRINCIPAL FINDINGS: Quantitative and qualitative data was collected in eight villages in Buyende and Kamuli districts, Eastern Uganda. Quantitative data on the number of persons treated by age and gender was identified from treatment registers in each village. Qualitative data was collected through semi-structured interviews with sub-county supervisors, participant observation and from focus group discussions with community leaders, community medicine distributors (CMDs), men, women who were pregnant or breastfeeding at the time of mass-treatment, and adolescent males and females. Findings include the following: (i) treatment registers are often incomplete making it difficult to obtain accurate estimates of the number of persons treated; (ii) males face more barriers to accessing treatment than women due to occupational roles which keep them away from households or villages for long periods, and males may be more distrustful of treatment; (iii) CMDs may be unaware of which medicines are safe for pregnant and breastfeeding women, resulting in women missing beneficial treatments.
CONCLUSIONS/SIGNIFICANCE: Findings highlight the need to improve community-level training in drug distribution which should include gender-specific issues and guidelines for treating pregnant and breastfeeding women. Accurate age and sex disaggregated measures of the number of community members who swallow the medicines are also needed to ensure proper monitoring and evaluation of treatment programmes.
a1935-2735